A meta-analysis suggested that the Asp298 (894T) and an intron-4 single-nucleotide polymorphism (SNP), but not the promoter -786C allele, in the endothelial NO synthase (eNOS) gene would increase the risk of ischemic heart disease (IHD). 1 Although based on studies of Ͼ23 000 subjects, this conclusion is amazing. The authors stated an increased susceptibility to cleavage of the Asp298-encoded eNOS enzyme, 1 but this was disproved. 2 Thus, no evidence for a functional role of these SNPs exists. In contrast, the -786C allele bears functional consequences, because it creates a binding site for a RPA-1 protein that blunts transcription 3 ; it is also in linkage disequilibrium and interacts with the Asp298 in causing endothelial dysfunction. 3 Serendipity or linkage disequilibrium with functional variants, as the -786C allele, in the eNOS and/or other genes might therefore explain the association of these SNPs with IHD. 1 The meta-analysis was underpowered to detect an association of the -786C allele with IHD, because of the few available studies. 1 Regrettably, two large studies that reported an association of this SNP with coronary artery disease were overlooked. 4,5 Therefore, had the authors meta-analyzed these studies, their conclusions might have been altogether different.
Response
We disagree that a functional role for Glu298Asp has been disproved or that a functional role for -786TϾC has been demonstrated unequivocally. Fairchild et al 1 suggested that preferential proteolytic cleavage of Asp298 observed in vitro was an artifact of nonspecific acid hydrolysis during sample preparation, but selective proteolysis of Asp298 in human vascular tissues, with a reduction in catalytic activity, has since been seen in samples prepared at neutral pH. 2 Promoter-reporter studies of -786TϾC have also been equivocal. 3 Linkage disequilibrium between -786TϾC and Glu298Asp polymorphisms is at best moderate. 4 Rossi et al 5 We limited analysis to an additive model for -786TϾC because of incomplete genotype information in two studies. The updated random-effect summary-odds ratio (OR) for the -786TϾC-ischemic heart disease (IHD) association (CC versus TT; 4882 cases and 9366 controls) was 1.30 ([95%CI: 1.01 to 1.66], Pϭ0.04). Significant heterogeneity was observed (Pϭ0.002), partially accounted for by Fatini et al. 7 When excluded, the summary OR decreased to 1.21 (0.96 to 1.53; Pϭ0.11). No publication bias was detected (Pϭ0.32). These data suggest an effect of the -786TϾC variant, but considerable uncertainty remains. In a cumulative meta-analysis, the -786TϾC-IHD association became positive only in 2004, but with wide confidence intervals. The summary OR does not yet appear stable to additional data. In contrast, the summary OR for Glu298Asp has been stable since 2001, and the confidence intervals have narrowed (data not shown).
In response to the additional points raised, results were homogeneous for coronary artery disease and myocardial infarction, and ethnic background was not a significant source of heterogeneity. No study has compared genotyping methods, and thus the optimal assay remains to be defined. Survival bias is only likely to be large if the polymorphism influences lethality. There was no evidence for this in Ϸ3100 subjects followed for 8 years, although power may have been low. 4 Confounding by other cardiovascular risk factors is an unlikely explanation of our findings. Inheritance of genetic variants is subject to a random assortment of maternal and paternal alleles at gamete formation, so the distribution of Glu298Asp and -786TϾC variants should be independent of other risk factors. 3, 4 Indeed, one advantage of genetic over classical observational studies is that the problem of classical confounding is overcome. 8 Heterogeneity between studies (and not confounding within studies) was evaluated by meta-regression, not "multivariate logistic regression analysis." Whether genetic risk is explained or modified by -786TϾC or intron-4 variants requires further clarification. The data available currently provide the strongest support for an association between Glu298Asp and IHD.
